Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.62 |
| ▸ | CNR2 | P34972 | 14/20 | 0.57 |
| ▸ | CNR1 | P21554 | 11/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.47 |
| ▸ | LDHA | P00338 | 2/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.47 |
| ▸ | MLNR | O43193 | 1/20 | 0.47 |
| ▸ | PDE9A | O76083 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351653 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL26112343 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL20911820 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL13214152 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL23765201 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL26136617 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL23627717 | 1.00 | OPRM1 (0.62) | OPRM1CNR2CNR1TRPV1NR1I2 | |
| SCHEMBL24538304 | 0.93 | OPRM1 (0.52) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL23008924 | 0.93 | OPRM1 (0.52) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL13214153 | 0.93 | OPRM1 (0.52) | OPRM1CNR2CNR1TRPV1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CALIBRATED THERAPEUTICS, LLC | 2023-06-01 | — | — | US | disclosed |
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CALIBRATED THERAPEUTICS, LLC | 2023-06-01 | — | — | US | disclosed |
| US-20230131989-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | MEDTERRA PHARMA LLC | 2023-04-27 | — | — | US | disclosed |
| US-20230131989-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | MEDTERRA PHARMA LLC | 2023-04-27 | — | — | US | disclosed |
| WO-2022049007-A1 | METHOD OF PREPARING CANNABINOIDS | GW Research Limited (GB) | 2022-03-10 | — | — | WO | disclosed |
| US-20090054376-A1 | BENZOFURAN DERIVATIVES WITH THERAPEUTIC ACTIVITIES | PHARMOS CORPORATION | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CNR2, CNR1, FAAH | OPRM1 153/4885CNR2 1/4885CNR1 2/4885 |
| US-20230131989-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | CNR2, CNR1, FAAH2 | OPRM1 515/4885CNR2 1/4885CNR1 2/4885 |
| US-20090054376-A1 | BENZOFURAN DERIVATIVES WITH THERAPEUTIC ACTIVITIES | CNR2, CNR1, TRPV1 | OPRM1 83/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.